Table of Contents Author Guidelines Submit a Manuscript
International Journal of Genomics
Volume 2017 (2017), Article ID 4832125, 11 pages
https://doi.org/10.1155/2017/4832125
Research Article

HuoXueJieDu Formula Alleviates Diabetic Retinopathy in Rats by Inhibiting SOCS3-STAT3 and TIMP1-A2M Pathways

1College of Basic Medicine, Key Laboratory of Ministry of Education (Syndromes and Formulas), Key Laboratory of Beijing (Syndromes and Formulas), Beijing University of Chinese medicine, Beijing 100029, China
2School of Public Health, Capital Medical University, Beijing 100069, China
3Key Laboratory of Systems Biology, CAS Center for Excellence in Molecular Cell Science, Innovation Center for Cell Signaling Network, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China
4Institute of Chinese Medicine, Beijing University of Chinese medicine, Beijing 100029, China
5Modern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
6Department of Bioinformatics, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China

Correspondence should be addressed to Jing Han, Ruixin Zhu, and Wei Wang

Hongliang Wang and Wei Xing contributed equally to this work.

Received 30 March 2017; Revised 30 June 2017; Accepted 8 October 2017; Published 29 November 2017

Academic Editor: Guoxun Chen

Copyright © 2017 Hongliang Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. H. Wang, D. Ling, L. Tu, P. van Wijngaarden, G. J. Dusting, and G. S. Liu, “Gene therapy for diabetic retinopathy: are we ready to make the leap from bench to bedside?” Pharmacology & Therapeutics, 2017. View at Publisher · View at Google Scholar
  2. M. S. Vasant, I. S. Kim, and D. K. Choi, “Recent update on the role of Chinese material medica and formulations in diabetic retinopathy,” Molecules, vol. 22, p. 76, 2017. View at Publisher · View at Google Scholar
  3. Q. Yao, J. Han, J. Yu, L. Huang, L. Pan, and W. Wang, “Effects of Huoxue Jiedu recipe on retinopathy in diabetic rats,” Zhong Guo Zhong Xi Yi Jie He Za Zhi, vol. 32, no. 3, pp. 362–366, 2012. View at Google Scholar
  4. Q. Yao, J. Han, L. Huang, J. Yu, and W. Wang, “Effects of Huoxue Jiedu recipe on retinopathy in early diabetic rats,” Zhong Guo Zhong Xi Yi Jie He Za Zhi, vol. 32, no. 9, pp. 1271–1274, 2012. View at Google Scholar
  5. Q. YAO, Diabetic Retinopathy Intervened by Huo Xue JieDu Formula, Beijing University of Chinese Medicine, Bei Jing, 2012.
  6. Q. Yao, J. Han, L. Huang, J. Yu, and W. Wang, “Effect of Huoxue Jiedu formula on vascular endothelial growth factor in retina of diabetic rats,” Zhong Hua Zhong Yi Yao Za Zhi, vol. 27, 2012. View at Google Scholar
  7. H. Jie, H. Gai-mei, W. Zhi-qian et al., “Effects of Huoxue Jiedu recipe on retinopathy in diabetic rats,” Zhong Guo Quan Ke Yi Xue, vol. 18, pp. 507–512, 2015. View at Google Scholar
  8. Q. Feng, W. Liu, S. S. Baker et al., “Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease,” Oncotarget, vol. 8, no. 17, pp. 27820–27838, 2017. View at Publisher · View at Google Scholar
  9. Y. Wang, W. Lin, C. Li et al., “Multipronged therapeutic effects of Chinese herbal medicine Qishenyiqi in the treatment of acute myocardial infarction,” Frontiers in Pharmacology, vol. 8, p. 98, 2017. View at Publisher · View at Google Scholar
  10. N. Nagai, S. Deguchi, H. Otake, N. Hiramatsu, and N. Yamamoto, “Therapeutic effect of cilostazol ophthalmic nanodispersions on retinal dysfunction in streptozotocin-induced diabetic rats,” International Journal of Molecular Sciences, vol. 18, 2017. View at Publisher · View at Google Scholar
  11. A. Baufeld, D. Koczan, and J. Vanselow, “Induction of altered gene expression profiles in cultured bovine granulosa cells at high cell density,” Reproductive Biology and Endocrinology, vol. 15, p. 3, 2017. View at Publisher · View at Google Scholar
  12. D. Streif, E. Iglseder, C. Hauser-Kronberger, K. G. Fink, M. Jakab, and M. Ritter, “Expression of the non-gastric H+/K+ ATPase ATP12A in normal and pathological human prostate tissue,” Cellular Physiology and Biochemistry, vol. 28, pp. 1287–1294, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. E. J. Hillmer, H. Zhang, H. S. Li, and S. S. Watowich, “STAT3 signaling in immunity,” Cytokine & Growth Factor Reviews, vol. 31, pp. 1–15, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. A. R. Hackett, D. H. Lee, A. Dawood et al., “STAT3 and SOCS3 regulate NG2 cell proliferation and differentiation after contusive spinal cord injury,” Neurobiology of Disease, vol. 89, pp. 10–22, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Song, S. Xu, H. Zhang et al., “TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway,” Journal of Experimental & Clinical Cancer Research, vol. 35, p. 148, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Bian, J. D. Yang, T. W. Guo et al., “Association study of the A2M and LRP1 genes with Alzheimer disease in the Han Chinese,” Biological Psychiatry, vol. 58, pp. 731–737, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Sethna, W. Feng, Q. Ding, A. J. Robison, Y. Feng, and H. Wang, “Enhanced expression of ADCY1 underlies aberrant neuronal signalling and behaviour in a syndromic autism model,” Nature Communications, vol. 8, article 14359, 2017. View at Publisher · View at Google Scholar
  18. C. Garbers, S. Aparicio-Siegmund, and S. Rose-John, “The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition,” Current Opinion in Immunology, vol. 34, pp. 75–82, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Jiang, Q. Zhang, C. Soderland, and J. J. Steinle, “TNFα and SOCS3 regulate IRS-1 to increase retinal endothelial cell apoptosis,” Cellular Signalling, vol. 24, pp. 1086–1092, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Lv, B. Sun, Z. Mai, M. Jiang, and J. Du, “STAT3 potentiates the ability of airway smooth muscle cells to promote angiogenesis by regulating VEGF signalling,” Experimental Physiology, vol. 102, pp. 598–606, 2017. View at Publisher · View at Google Scholar
  21. H. Okazaki, S. Tokumaru, Y. Hanakawa et al., “Nuclear translocation of phosphorylated STAT3 regulates VEGF-A-induced lymphatic endothelial cell migration and tube formation,” Biochemical and Biophysical Research Communications, vol. 412, pp. 441–445, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Hedvat, D. Huszar, A. Herrmann et al., “The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors,” Cancer Cell, vol. 16, pp. 484–497, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. G. He and M. Karin, “NF-κB and STAT3 - key players in liver inflammation and cancer,” Cell Research, vol. 21, pp. 159–168, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Mishra, V. Baranwal, R. K. Mishra, S. Sharma, B. Paul, and A. C. Pandey, “Titanium dioxide nanoparticles augment allergic airway inflammation and Socs3 expression via NF-κB pathway in murine model of asthma,” Biomaterials, vol. 92, pp. 90–102, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Ehlting, W. S. Lai, F. Schaper et al., “Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-α involves activation of the MKK6/p38MAPK/MK2 cascade,” Journal of Immunology, vol. 178, pp. 2813–2826, 2007. View at Publisher · View at Google Scholar
  26. Y. Jiang, S. Thakran, R. Bheemreddy, W. Coppess, R. J. Walker, and J. J. Steinle, “Sodium salicylate reduced insulin resistance in the retina of a type 2 diabetic rat model,” PLoS One, vol. 10, article e0125505, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Al-Shabrawey, M. Bartoli, A. B. El-Remessy et al., “Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy,” Investigative Ophthalmology & Visual Science, vol. 49, pp. 3231–3238, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. J. H. Yun, S. W. Park, K. J. Kim et al., “Endothelial STAT3 activation increases vascular leakage through downregulating tight junction proteins: implications for diabetic retinopathy,” Journal of Cellular Physiology, vol. 232, pp. 1123–1134, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. H. W. Kim, J. L. Kim, H. K. Lee, D. Y. Hur, I. H. Yun, and S. D. Kim, “Enalapril alters expression of key growth factors in experimental diabetic retinopathy,” Current Eye Research, vol. 34, pp. 976–987, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Jiang, S. Thakran, R. Bheemreddy et al., “Pioglitazone normalizes insulin signaling in the diabetic rat retina through reduction in tumor necrosis factor α and suppressor of cytokine signaling 3,” The Journal of Biological Chemistry, vol. 289, pp. 26395–26405, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. G. M. Hao, Y. G. Liu, Y. Wu et al., “The protective effect of the active components of ERPC on diabetic peripheral neuropathy in rats,” Journal of Ethnopharmacology, vol. 202, pp. 162–171, 2017. View at Publisher · View at Google Scholar
  32. X. Liu, X. Zhang, L. Ye, and H. Yuan, “Protective mechanisms of berberine against experimental autoimmune myocarditis in a rat model,” Biomedicine & Pharmacotherapy, vol. 79, pp. 222–230, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Wu, Y. Yu, A. Szabo, M. Han, and X. F. Huang, “Central inflammation and leptin resistance are attenuated by ginsenoside Rb1 treatment in obese mice fed a high-fat diet,” PLoS One, vol. 9, article e92618, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. G. P. Botta, M. Reichert, M. J. Reginato, S. Heeg, A. K. Rustgi, and P. I. Lelkes, “ERK2-regulated TIMP1 induces hyperproliferation of K-RasG12D-transformed pancreatic ductal cells,” Neoplasia, vol. 15, pp. 359–372, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. F. J. Descamps, E. Martens, D. Kangave et al., “The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage,” Experimental Eye Research, vol. 83, pp. 401–407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. H. W. Jackson, V. Defamie, P. Waterhouse, and R. Khokha, “TIMPs: versatile extracellular regulators in cancer,” Nature Reviews Cancer, vol. 17, pp. 38–53, 2017. View at Publisher · View at Google Scholar
  37. M. C. Sanchez, J. D. Luna, P. F. Barcelona et al., “Effect of retinal laser photocoagulation on the activity of metalloproteinases and the α2-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy,” Experimental Eye Research, vol. 85, pp. 644–650, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. W. M. Freeman, G. V. Bixler, R. M. Brucklacher et al., “A multistep validation process of biomarkers for preclinical drug development,” The Pharmacogenomics Journal, vol. 10, pp. 385–395, 2010. View at Publisher · View at Google Scholar · View at Scopus